Back to 
BAMCO Inc.
BAMCO Inc.
LGND
3 quarters
Position history for BAMCO Inc.'s holdings in Ligand Pharmaceuticals Incorporated
No. BAMCO exited its LGND (Ligand Pharmaceuticals) position in Q3 2019. Its Q2 2019 13F listed 497 shares worth $57,000. BAMCO first reported LGND in Q1 2019 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$249,000
Total Shares Change
-1,977
Quarter-by-Quarter History
Other major holders of LGND: BlackRock, Inc., Vanguard Group Inc.